US industry vows to keep fighting Japanese price move
This article was originally published in Clinica
US exporters stand to lose a $500 million-annual market and local healthcare will suffer if Japan proceeds with the introduction of foreign reference pricing for medical devices, as planned. That is the view of AdvaMed, the US Advanced Medical Technology Association, which last week said it would actively seek to steer Japan away from its reference pricing initiative via bilateral talks. If it fails, the US may pursue its complaint through the offices of the World Trade Organization, AdvaMed's Jeff Ezell and Ed Rozynski explained during a telephone briefing.